Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical study on nivolumab for Hodgkin lymphoma, while retaining key identifiers such as the study's grant number and collaborators. The revision number has also been updated.SummaryDifference39%
- Check11 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check54 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check68 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check76 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check90 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.